跳至主要内容
临床试验/CTRI/2024/11/076238
CTRI/2024/11/076238尚未招募2/3 期

A Randomized Controlled Clinical Study to Evaluate the Efficacy of Hinguvachadi gutika and tablet Mefanamic acid and Dicylomine in the management of Kashtaarthva.

Tilak Ayurveda Mahavidyalaya1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年11月18日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Decrease in pain, duration and intensity

研究概览

简要总结

The study will be intervened by the treatment of HIngu-vachadi Gutika and tab Mefanamic acid and Dicylomine to group A and group B respectively. The efficacy of the therapy will be assessed on the basis of subjective criteria for statistical analysis. Scoring will be designed according to the severity of symptoms. The subjective gradation of symptoms will be done as follows and the intensity of each symptom will be calculated before treatment, after treatment and after follow up. The effect of treatment result will be assessed in regards to clinical signs and symptoms on the basis of grading and scoring system. The signs and symptoms will be assessed by adopting the suitable scoring method

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 35.00 Year(s)(—)
性别
Female

入选标准

  • All the women unmarried or married complaining of painfull menstruration at least 3 consecutive cycle.

排除标准

  • Known Cases of secondary dysmenorrhea with pelvic pathology prolapse ,uterine fibroid, pelvic endometriosis, cervical stenosis ,Pelvic inflammatory Diseases.
  • Participant with intrauterine contraceptive device 3) Participant is on hormonal therapy.

结局指标

主要结局

Decrease in pain, duration and intensity

时间窗: 3 days

次要结局

  • Decrease in pain, duration, clots and intensity(5 days)

研究者

发起方
Tilak Ayurveda Mahavidyalaya
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Mayur Pratapsing Ingale

Tilak Ayurved Mahavidyalaya

研究点 (1)

Loading locations...

相似试验